Acute Respiratory Infections Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting acute respiratory infections clinical trials across 5 countries. Studies span Not Applicable. Top locations include Shanghai, Shanghai Municipality, China, Beaulieu, France, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Acute Respiratory Infections Trials at a Glance

7 actively recruiting trials for acute respiratory infections are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Shanghai, Beaulieu, and Beijing. Lead sponsors running acute respiratory infections studies include Centre Hospitalier Emile Roux, Fudan University, and BioMérieux.

Browse acute respiratory infections trials by phase

About Acute Respiratory Infections Clinical Trials

Looking for clinical trials for Acute Respiratory Infections? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acute Respiratory Infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acute Respiratory Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens

Respiratory Tract Infections (RTI)Acute Respiratory Infections (ARIs)Respiratory Syndrome, Acute, Severe
Huashan Hospital2,398 enrolled31 locationsNCT07694648
Recruiting

FebriDx® Pediatric Validation Study

Acute Respiratory Infections (ARIs)
Lumos Diagnostics800 enrolled10 locationsNCT07211997
Recruiting

Epidemiological Characteristics and Clinical Burden of RSV Infection in Children Under 24 Months in Ho Chi Minh City (2026-2028)

Acute Respiratory Infections (ARIs)
Tam Anh Research Institute2,000 enrolled3 locationsNCT07640581
Recruiting
Not Applicable

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

Acute Respiratory Infections (ARIs)
BioMérieux800 enrolled2 locationsNCT07513519
Recruiting

The Fever Clinic Acute Respiratory Cohort

Influenza Like-illnessCommunity-acquired PneumoniaFebrile Illnesses+2 more
Fudan University1,000 enrolled1 locationNCT07278700
Recruiting
Not Applicable

Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial

Acute Respiratory Infections
Centre Hospitalier Emile Roux1,200 enrolled12 locationsNCT06569160
Recruiting

Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian Emergency Department with suspected COVID-19.

COVID-19InfectionAcute Respiratory Infections
Planet Innovation300 enrolled1 locationACTRN12620001029987